Scientific illustration for Cannabis use in chronic pancreatitis: A narrative review.

Cannabis use in chronic pancreatitis: A narrative review.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] Review Relevant
🤖

AI Summary

Chronic pancreatitis is a serious disease that causes persistent abdominal pain and currently has limited treatment options. This review examined what we know about using cannabis and cannabis-derived products to help manage the pain and symptoms of chronic pancreatitis. The researchers found that cannabis use among chronic pancreatitis patients is becoming more common, particularly among younger men who are also taking opioid pain medications. This is important because it suggests patients are turning to cannabis as an alternative when conventional treatments aren't working well enough.

The research results are mixed and somewhat encouraging but not conclusive. One study found that medical cannabis was associated with lower daily doses of opioids, which is significant since opioids carry their own risks of addiction and side effects. However, a more rigorous randomized controlled trial (which is the gold standard for medical research) showed that THC alone did not substantially reduce abdominal pain. A few small, lower-quality studies suggested that cannabis might help hospitalized patients improve, but these findings are preliminary and need more investigation to be considered reliable.

The authors emphasize that while cannabis appears to be a treatment option some patients are exploring, the scientific evidence is still quite limited and of variable quality. More research is needed to determine whether medical cannabis could become a legitimate, evidence-based therapy for chronic pancreatitis pain. Until better evidence exists, patients interested in cannabis should discuss it with their healthcare providers, who can help weigh potential benefits against risks and consider individual circumstances.

💡 Key Findings

1
Cannabis use in chronic pancreatitis patients is increasing and more common among younger males who also take chronic opioids and experience chronic abdominal pain
Good
75%
2
Medical cannabis was associated with decreased mean daily opioid use in one retrospective study, suggesting potential for opioid reduction
Good
60%
3
THC did not significantly decrease abdominal pain in a randomized controlled trial, indicating limited efficacy for pain management
High
80%
4
Several very low-quality studies showed improved outcomes in hospitalized chronic pancreatitis patients who used cannabis, but findings are preliminary
Moderate
40%
5
The overall evidence for cannabis use in chronic pancreatitis is limited and mostly low-quality, warranting further investigation
High
85%

📄 Original Abstract

Chronic pain is a debilitating complication of chronic pancreatitis for which treatment options are limited. The goal of this narrative review was to summarize the existing evidence surrounding use of cannabis and its derivatives in chronic pancreatitis patients. Cannabis use in chronic pancreatitis is increasing and more prevalent in patients who are younger, male, take opioids chronically, and have chronic abdominal pain. In one retrospective study medical cannabis was associated with decreased mean daily opioid use while in a randomized control trial THC did not significantly decrease abdominal pain. Several very low-quality studies showed improved outcomes in hospitalized chronic pancreatitis patients who used cannabis. The existing evidence surrounding cannabis use in chronic pancreatitis is limited and mostly low-quality. Further investigation is warranted to explore whether medical cannabis could represent an effective therapy for patients with chronic pancreatitis.

Explore More Research

Stay informed about the latest cannabis science.

Track your cannabis journey with AI

Get personalized strain recommendations based on your preferences